Luca Morandi

994 total citations
33 papers, 512 citations indexed

About

Luca Morandi is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Infectious Diseases. According to data from OpenAlex, Luca Morandi has authored 33 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 6 papers in Infectious Diseases. Recurrent topics in Luca Morandi's work include COVID-19 Clinical Research Studies (6 papers), Eosinophilic Disorders and Syndromes (5 papers) and Asthma and respiratory diseases (5 papers). Luca Morandi is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Eosinophilic Disorders and Syndromes (5 papers) and Asthma and respiratory diseases (5 papers). Luca Morandi collaborates with scholars based in Italy, Australia and Netherlands. Luca Morandi's co-authors include Alberto Papi, Federico Bellini, Nicola Scichilone, P. Paggiaro, Fulvio Braido, Alessandro Sanduzzi, Pierachille Santus, Francesco Blasi, Giorgio Walter Canonica and Luca Richeldi and has published in prestigious journals such as Blood, Frontiers in Immunology and Journal of Molecular Medicine.

In The Last Decade

Luca Morandi

29 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Morandi Italy 8 157 137 78 57 54 33 512
Heung Bum Lee South Korea 15 220 1.4× 147 1.1× 31 0.4× 67 1.2× 72 1.3× 55 582
Subhash Popli United States 16 144 0.9× 114 0.8× 27 0.3× 33 0.6× 144 2.7× 38 615
Mohammad Shameem India 9 139 0.9× 84 0.6× 67 0.9× 42 0.7× 85 1.6× 73 371
Ahmet Zülfikar Akelma Türkiye 11 81 0.5× 52 0.4× 59 0.8× 47 0.8× 50 0.9× 54 350
G. Ainslie South Africa 12 246 1.6× 257 1.9× 109 1.4× 43 0.8× 84 1.6× 20 492
N. D. Vaziri United States 13 114 0.7× 52 0.4× 37 0.5× 87 1.5× 133 2.5× 29 582
Maria Papale Italy 17 309 2.0× 141 1.0× 71 0.9× 79 1.4× 87 1.6× 57 656
A Blasco Spain 16 89 0.6× 88 0.6× 71 0.9× 52 0.9× 142 2.6× 63 864
Ahmad Amin Iran 17 119 0.8× 83 0.6× 40 0.5× 95 1.7× 112 2.1× 98 742
Sanja Popović‐Grle Croatia 16 340 2.2× 147 1.1× 77 1.0× 162 2.8× 48 0.9× 66 703

Countries citing papers authored by Luca Morandi

Since Specialization
Citations

This map shows the geographic impact of Luca Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Morandi more than expected).

Fields of papers citing papers by Luca Morandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Morandi. The network helps show where Luca Morandi may publish in the future.

Co-authorship network of co-authors of Luca Morandi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Morandi. A scholar is included among the top collaborators of Luca Morandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Morandi. Luca Morandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gentili, Valentina, Daria Bortolotti, Luca Morandi, et al.. (2023). Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells. Frontiers in Bioscience-Landmark. 28(7). 2 indexed citations
2.
Vezzani, Bianca, Mariasole Perrone, Marianna Carinci, et al.. (2023). SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia. Journal of Inflammation. 20(1). 40–40. 2 indexed citations
3.
Mei, Federico, Mario Tamburrini, Luca Morandi, et al.. (2023). Management of malignant pleural effusion in Italian clinical practice: a nationwide survey. BMC Pulmonary Medicine. 23(1). 252–252. 1 indexed citations
4.
Rizzo, Roberta, Daria Bortolotti, Luca Morandi, et al.. (2022). Humoral and adaptive immune responses to the SARS-CoV-2 vaccine. International Journal of Infectious Diseases. 122. 412–414. 2 indexed citations
5.
Morandi, Luca, Laura Marconato, Marina Aralla, et al.. (2021). Validation of oral brushing as a non‐invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis. Veterinary and Comparative Oncology. 19(3). 501–509. 1 indexed citations
6.
Contoli, Marco, Alberto Papi, L. Tomassetti, et al.. (2021). Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients. Frontiers in Immunology. 12. 648004–648004. 58 indexed citations
7.
Papi, Alberto, Francesco Blasi, Giorgio Walter Canonica, et al.. (2020). Treatment strategies for asthma: reshaping the concept of asthma management. Allergy Asthma and Clinical Immunology. 16(1). 75–75. 82 indexed citations
8.
Roncarati, Roberta, Laura Lupini, Elena Miotto, et al.. (2020). Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer. Molecular Oncology. 14(9). 2163–2175. 23 indexed citations
9.
Papi, Alberto, Luca Morandi, & Leonardo M. Fabbri. (2020). Prevention of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine. 41(3). 453–462. 6 indexed citations
10.
Morandi, Luca, et al.. (2019). The expanding role of endobronchial ultrasound in patients with centrally located intrapulmonary tumors. Lung Cancer. 134. 194–201. 10 indexed citations
11.
Morandi, Luca, et al.. (2019). The expanding role of endobronchial ultrasound in patients with centrally located intrapulmonary tumors. PA4772–PA4772. 2 indexed citations
12.
Morandi, Luca, Rosa Rinaldi, Pio Maniscalco, et al.. (2018). Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma. Journal of Thoracic Disease. 10(6). E442–E446. 3 indexed citations
13.
Bellini, Federico, Fulvio Braido, P. Paggiaro, et al.. (2014). Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.. Pulmonary Pharmacology & Therapeutics. 27(2). 129–138. 177 indexed citations
14.
Papi, Alberto, Nicola Scichilone, Alida Benfante, Luca Morandi, & Federico Bellini. (2014). Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Related Outcome Measures. 5. 153–153. 32 indexed citations
15.
Morandi, Luca, et al.. (1996). An unusual association: celiac disease and Becker muscular dystrophy.. PubMed. 91(7). 1459–60.
16.
Pagano, Patrick J., et al.. (1990). A modelistic approach to evaluate the factors affecting the 137Cs transfer from mother to fetus in cattle.. PubMed. 97(11). 452–6. 1 indexed citations
17.
Morandi, Luca, et al.. (1957). Elementos curriculares para crear sentdo geométrico en alumnos y profesores. PubMed. 87(26). 249–258. 6 indexed citations
18.
Morandi, Luca, et al.. (1955). Morphologisch-biologische Untersuchungen an eosinophilen Granulozyten. Pathobiology. 18(5). 1164–1166.
19.
Marti, Hanna, et al.. (1955). �ber die Natur der Charcot-Leydenschen Kristalle. Journal of Molecular Medicine. 33(43-44). 1040–1043. 2 indexed citations
20.
Löffler, W., et al.. (1952). [Transient pulmonary infiltrations with blood eosinophilia caused by therapeutic oil injections].. PubMed. 82(31). 777–85. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026